The cost of surveillance following treatment of ovarian cancer

Gynecol Oncol. 2013 Dec;131(3):501-2. doi: 10.1016/j.ygyno.2013.10.034.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • CA-125 Antigen / analysis*
  • Female
  • Humans
  • Membrane Proteins / analysis*
  • Neoplasm Recurrence, Local / diagnosis*
  • Neoplasm Recurrence, Local / economics*
  • Ovarian Neoplasms / diagnosis*
  • Ovarian Neoplasms / economics*

Substances

  • CA-125 Antigen
  • MUC16 protein, human
  • Membrane Proteins